71 studies found for:    Open Studies | "Antiretroviral Therapy, Highly Active" OR HAART
Show Display Options
Rank Status Study
21 Unknown  Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Antiretroviral (ARV) Naive Patients Starting Treatment With Anti-HCV Therapy
Conditions: HIV Infections;   Hepatitis C
Interventions: Drug: LPV/r;   Drug: Nucleoside Reverse Transcriptase Inhibitors;   Drug: PEG-IFNa 2a;   Drug: Ribavirin
22 Recruiting Use of Incentives to Retain Drug Users in HIV Therapy
Condition: HIV Infection
Intervention: Other: monetary reinforcer
23 Not yet recruiting Atorvastatin for HAART Suboptimal Responders
Condition: Acquired Immune Deficiency Syndrome Virus
Interventions: Other: 'atorvastatin, Lipitor®';   Drug: Placebo
24 Recruiting A Study of Selumetinib in Patients With Kaposi's Sarcoma
Condition: AIDS-related Kaposi's Sarcoma
Intervention: Drug: Selumetinib
25 Unknown  Acquired Immunodeficiency Syndrome(AIDS) and Tuberculosis(Tb) Co-infection Treatment Strategies Study of China.
Condition: AIDS
Intervention: Drug: INH RIF Rifb PZA EMB AZT 3TC D4T EFV
26 Recruiting Children With HIV and Asthma (CHIVAS)
Condition: T Cell Response to Asthma in HIV-infected Patients Before and After Starting Treatment
Intervention: Drug: HAART
27 Not yet recruiting Prospective HIV Chemotherapy Cohort Study
Conditions: HIV;   Cancer
Intervention: Other: No intervention for this study
28 Unknown  Nevirapine Clearance After Short-term Highly Active Antiretroviral Therapy (HAART) for Prevention of Mother to Child Transmission of HIV (PMTCT)
Conditions: NVP Plasma Level;   NVP Related Mutation;   3TC Related Mutation
Intervention: Drug: AZT/3TC 2 weeks after delivery
29 Unknown  Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Patients Starting Treatment With Anti-Hepatitis C Virus (HCV) Therapy
Conditions: HIV Infections;   Hepatitis C
Interventions: Drug: LPV/r;   Drug: PEG-IFNa 2a;   Drug: Ribavirin;   Drug: NUCS
30 Recruiting HAART 200 Aortic Valve Annuloplasty During Bicuspid Aortic Valve Reconstruction
Condition: Aortic Insufficiency
Intervention: Device: Bicuspid Aortic Valve Repair
31 Unknown  Simultaneous Versus Sequential Antiretroviral Therapy (ARV) Therapy and Mycobacterium Tuberculosis (MTB) Treatment
Conditions: HIV;   AIDS;   Tuberculosis
Interventions: Drug: Simultaneous ARV and antiMTB;   Drug: Deferred RV and antiMTB treatment
32 Recruiting Effect of HIV Infection and Highly Active Antiretroviral Treatment (HAART) on Bone Homeostasis
Conditions: HIV Infection;   Osteopenia;   Osteoporosis
Intervention:
33 Unknown  Switch to Darunavir/r + Maraviroc QD in Patients With R5 Tropism by Viral DNA Genotyping (GUSTA)
Condition: HIV Infection
Interventions: Drug: Maraviroc, Darunavir/r;   Drug: current antiretroviral therapy with 3 drugs
34 Recruiting Dose Escalation Study of Cyclophosphamide in HIV-Infected Subjects on HAART Receiving SB-728-T
Condition: HIV
Intervention: Genetic: SB-728-T
35 Recruiting Perinatal Antiretroviral Intensification for PMTCT of HIV in Late Comers
Condition: HIV Infections
Intervention: Drug: Nevirapine, zidovudine, lamivudine
36 Unknown  Metabolic Safety of Raltegravir Versus Darunavir in HIV Naive Patients
Conditions: Cardiovascular Disease;   HIV Infections
Intervention:
37 Unknown  Optimal Time to Initiate Antiretroviral Therapy in HIV & TB Coinfected Adults Being Treated for Tuberculosis
Conditions: Acquired Immunodeficiency Syndrome;   Tuberculosis
Intervention: Other: Comparison of different treatment strategies
38 Recruiting HCV Evolution in HIV/HCV (Genotype 1) Coinfected Patients Treated With Fosamprenavir
Conditions: Chronic HIV Infection;   HCV Coinfection
Intervention: Drug: Fosamprenavir
39 Recruiting Reducing Heavy Drinking to Optimize HIV/AIDS Treatment and Prevention
Condition: Reduction in Heavy Drinking in Patients With HIV
Interventions: Drug: Naltrexone;   Other: Placebo + Medication Management/Medication Coaching
40 Recruiting Trends of Morbidity and Mortality Among Thai HIV-infected and HIV-uninfected Patients: a Five-year Prospective Cohort Study
Conditions: HIV Infection;   Healthy
Intervention:

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years